These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36280529)

  • 1. Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.
    Midenberg E; Higgins MI; Schmeusser BN; Patil DH; Zaldumbide J; Martini DJ; Steele S; Williams M; Nabavizadeh R; Psutka SP; Ogan K; Bilen MA; Master VA
    Urol Oncol; 2023 Jan; 41(1):50.e19-50.e26. PubMed ID: 36280529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
    Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J; Zheng B; Narayan VM; Joshi SS; Ogan K; Psutka SP; Bilen MA; Master VA
    Clin Genitourin Cancer; 2023 Aug; 21(4):475-482.e4. PubMed ID: 37210313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy.
    Lee J; Suh J; Song C; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H
    Ann Surg Oncol; 2022 Apr; 29(4):2473-2479. PubMed ID: 34625877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma.
    Makino T; Izumi K; Iwamoto H; Kadomoto S; Mizokami A
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum low-density lipoprotein cholesterol is an independent prognostic factor in patients with renal cell carcinoma after nephrectomy.
    Cui F; Zhou H; Lv D; Wen J; Gong Q; Rong Y; Kang Y; Jia M; Shuang W
    Lipids Health Dis; 2023 Feb; 22(1):26. PubMed ID: 36814277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of prognostic nutritional index in renal cell carcinomas.
    Tang Y; Liang J; Liu Z; Zhang R; Zou Z; Wu K; Lu Y; Wei X
    Medicine (Baltimore); 2021 Mar; 100(10):e25127. PubMed ID: 33725913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
    Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
    Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.
    Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Costello BA; Thompson RH; Stewart-Merrill SB; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK
    J Urol; 2016 Feb; 195(2):270-6. PubMed ID: 26292038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Sharma P; Zargar-Shoshtari K; Caracciolo JT; Fishman M; Poch MA; Pow-Sang J; Sexton WJ; Spiess PE
    Urol Oncol; 2015 Aug; 33(8):339.e17-23. PubMed ID: 26094169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).
    Ko K; Park YH; Lee JW; Ku JH; Kwak C; Kim HH
    BJU Int; 2013 Oct; 112(6):775-80. PubMed ID: 24028765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
    Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
    Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Factor in Patients Undergoing Nephrectomy for Non-Metastatic Renal Cell Carcinoma: Propensity Score Matching Analysis.
    Won I; Shim SR; Kim SI; Kim SJ; Cho DS
    Clin Genitourin Cancer; 2022 Jun; 20(3):e253-e262. PubMed ID: 35241381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy.
    Corcoran AT; Kaffenberger SD; Clark PE; Walton J; Handorf E; Piotrowski Z; Tomaszewski JJ; Ginzburg S; Mehrazin R; Plimack E; Chen DY; Smaldone MC; Uzzo RG; Morgan TM; Kutikov A
    BJU Int; 2015 Sep; 116(3):351-7. PubMed ID: 25123843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
    Schmeusser BN; Biermann H; Nicaise EH; Ali AA; Patil DH; Midenberg E; Helman T; Armas-Phan M; Nabavizadeh R; Joshi SS; Narayan VM; Bilen MA; Psutka SP; Ogan K; Master VA
    Oncologist; 2023 Dec; 28(12):e1219-e1229. PubMed ID: 37540787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.
    Yang H; Yin K; Wang Y; Xia M; Zhang R; Wang W; Chen J; Wang C; Shuang W
    J Diabetes; 2019 Dec; 11(12):993-1001. PubMed ID: 31141620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
    Shim SR; Kim SJ; Kim SI; Cho DS
    World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus.
    Watanabe S; Ishihara H; Takagi T; Kondo T; Ishiyama R; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Ishida H; Tanabe K
    Jpn J Clin Oncol; 2021 Apr; 51(5):819-825. PubMed ID: 33558883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.